< Back to Schedule

Parallel Session: Hepatobiliary Neoplasia: Clinical

Monday, November 16
 
9:00 am
 - 
10:30 am

Speakers

No items found.

About the Session

Watch this live session to see some the top research in Hepatobiliary Neoplasia. Content will only be aired on this date, at this time. Don't miss it!

  • Precise Medicine Using a New Subclassification and Clinical Management for Barcelona Clinic Liver Cancer State C Hepatocelluar Carcinoma: A Multicentre Study
    Presenting Author Chih Wen Lin
  • AMAP Risk Score Predicts Hepatocellular Carcinoma Development in Chronic Hepatitis Patients: An International Cohort Collaboration
    Presenting Author Rong Fan
  • Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C and Stage-3 Liver Fibrosis After Sustained Virological Response (SVR) with Direct-Acting Antivirals (DAA)
    Presenting Author Maria Sanchez-Azofra
  • Striking Rural-Urban Disparities in Hepatocellular Carcinoma Trends in the United States, 1995-2016
    Presenting Author Christina Gainey
  • Association of Aspirin and Statin Use with Hepatocellular Carcinoma Risk in Treatment-Naïve Non-Cirrhotic Patients with Chronic Hepatitis B
    Presenting Author Won-Mook Choi
  • Outcomes of Transplantation for HBV vs. HCV-Related HCC Impact of DAA HCV Therapy in a National Analysis of > 18,0000 Patients
    Presenting Author Parissa Tabrizian